Neogenomics: EMSCULPT NEO Enhances Astronaut Tibor Kapu's Training for ISS Mission

### EMSCULPT NEO: Advancing Astronaut Preparation with Innovative Technology

BTL’s flagship device, EMSCULPT NEO, plays a pivotal role in preparing Hungarian research astronaut Tibor Kapu for his upcoming mission aboard the International Space Station (ISS). As part of the HUNOR (Hungarian To Orbit) program, EMSCULPT NEO is integrated into Kapu's rigorous pre-flight training regimen. Research shows that astronauts can experience up to a 30% loss in muscle mass during space missions, making effective muscle conditioning crucial for their performance and health in microgravity environments. This collaboration not only underscores the device's innovative capabilities but also positions BTL as a key player in the intersection of medical technology and space exploration.

Dr. Nóra Sydó, a cardiologist and sports medicine expert from Semmelweis University, leads the conditioning program that incorporates EMSCULPT NEO. She emphasizes the device's efficacy in enhancing muscle performance and recovery, noting that medical assessments indicate significant improvements in muscle hypertrophy, body composition, and cardiopulmonary fitness. The comprehensive conditioning protocol that includes EMSCULPT NEO aims to boost endurance, strength, balance, and recovery, achieving results that surpass traditional training methods. This integration of advanced technology into astronaut training highlights the importance of innovative medical devices in addressing the unique challenges faced by astronauts.

Tomas Schwarz, CEO of BTL Enterprise Group, expresses pride in the role of EMSCULPT NEO in astronaut training, illustrating the broader societal benefits of such technologies. The device, which employs patented muscle-stimulation technology, is not only beneficial for astronauts but also serves athletes and patients suffering from muscle loss. BTL’s ongoing commitment to innovation is evident in the versatility and effectiveness of EMSCULPT NEO, demonstrating its potential to improve lives across diverse populations and settings. This collaboration signifies a remarkable achievement for BTL, reinforcing the value of advanced medical technologies in extreme conditions and their impact on human health and performance.

In addition to its role in space training, the EMSCULPT NEO device has gained traction in various medical fields, including aesthetics and functional medicine. Its widespread adoption in thousands of medical practices showcases the growing recognition of its benefits and effectiveness. As BTL continues to innovate, the implications of its technologies extend beyond space exploration, potentially transforming recovery and conditioning practices in multiple domains.

The collaboration between BTL and the HUNOR program exemplifies the future of medical technology, where advancements not only enhance human capabilities in extreme environments but also contribute to the overall enhancement of health and well-being on Earth.